We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mouth Swab Molecular Test for Tuberculosis Validated

By LabMedica International staff writers
Posted on 22 Jan 2020
Image: PrimeStore Molecular Transport Medium (MTM) is the first molecular transport device designed to inactivate pathogens and stabilize both RNA and DNA for downstream molecular testing and characterization (Photo courtesy of Longhorn Vaccines and Diagnostics).
Image: PrimeStore Molecular Transport Medium (MTM) is the first molecular transport device designed to inactivate pathogens and stabilize both RNA and DNA for downstream molecular testing and characterization (Photo courtesy of Longhorn Vaccines and Diagnostics).
Clinical investigators are testing an approach being developed to diagnose tuberculosis using mouth swabs, which could become an alternate approach to sample collection methods currently used to do tuberculosis (TB) testing.

Partly because of the convenience of the collection method, the technique is helping increase access to testing and finding people with TB that have been undetected by traditional testing methods. For individuals with latent TB infection, the host maintains a dynamic relationship with Mycobacterium tuberculosis through the regulation of available nutrients as well as the innate and acquired immune systems.

Scientists at the University of Pretoria (Pretoria, South Africa) and their colleagues collected and tested samples from people during house visits in an urban setting in South Africa with a high prevalence of TB and human immunodeficiency viruses (HIV). The team used flocked swabs to collect oral salivary specimens from 73 adults. Each person had a cough and one or more risk factors for TB, including previous TB, or was asymptomatic but residing with someone diagnosed with TB.

The investigators combined the swab samples that they had collected with PrimeStore Molecular Transport Medium (MTM, Longhorn Vaccines and Diagnostics, San Antonio, TX, USA) to enable microbial inactivation, DNA stabilization, and transportation of the specimens at ambient temperature to a nearby laboratory. The group detected M. tuberculosis DNA in 24, or 32.9%, of the 73 samples using Longhorn's polymerase chain reaction (PCR) diagnostic assay running on a Roche LightCycler platform (Roche Diagnostics, Basel, Switzerland).

P. Bernard Fourie, PhD, a professor of medical microbiology and TB specialist, said, “The approach holds promise as an easy to perform, safe, and patient-friendly procedure for triaging people who are presumed to have TB at the household level, and it provides a basis for targeted patient follow-up.”

Related Links:
University of Pretoria
Longhorn Vaccines and Diagnostics
Roche Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Platelet Function Analyzer
PL-12

Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more